The dairy industry has seen a number of recent recalls and regulatory actions related to Listeria monocytogenes raising questions about what more the industry can do to ensure safe products. The Food and Drug Administration (FDA) recently issued revised draft guidance regarding the control of Listeria monocytogenes (Lm) in ready-to-eat (RTE) foods, which covers many dairy products. The 2017 draft guidance expands on the version initially issued by FDA in 2008. Along with added details on many topics, the 2017 draft guidance also changes several key recommendations, particularly with respect to the recommended corrective actions that should be taken following environmental and product testing. Most importantly, the draft guidance encourages a “seek and destroy" approach, allowing aggressive testing by industry to find harborage sites for Lm in and around processing equipment. This new line of thinking by FDA is a welcome change for the industry, which should lead to better control of Lm in dairy plants, less recalls and greater protection of public health.
To facilitate a deeper discussion into the pros and cons of this new FDA paradigm and other details in FDA's guidance, join IDFA for this webinar-based discussion with your colleagues in the industry and hear key insights from IDFA's outside legal counsel, Joe Levitt from Hogan Lovells, former director of FDA's Center for Food Safety and Applied Nutrition (CFSAN).
This frank discussion, with IDFA members only, will facilitate the development of a robust set of comments back to FDA on the draft guidance to help ensure the final guidance best serves our interests, so don't miss this opportunity!
When: March 2, 2017 | 1:00 - 2:30 p.m. Eastern Time
John T. Allan, III, MS, Vice President of Regulatory Affairs & International Standards, International Dairy Foods Association
Joseph Levitt, Partner, Hogan Lovells US LLP